Alveolus Bio is a clinical phase company creating therapeutics for chronic lung disease with an interdisciplinary team of experts in respiratory medicine and microbiome science. Their pre-clinical programs include inhalable, live biotherapeutic products for Chronic Obstructive Pulmonary Disease (COPD), Bronchopulmonary Dysplasia (BPD), Pulmonary Fibrosis, lung injury secondary to viral illness, and Neutrophilic Asthma. Since microbial signature changes in the lungs are associated with inflammation and respiratory disease progression, Alveolus Bio attempts to use anti-inflammatory commensal bacteria strains and byproducts as a direct, inhalable treatment for lung disease.

Alveolus Bio

Founded: 2021
Location: Birmingham, AL
Employee range: 1 - 10
Clinical stage: Clin0
Therapy area: COPD
Drug types: LNG
Lead product: AB1000

Drug notes:

About:

Jobs: